Pre‐emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein–Barr virus‐associated lymphoproliferative disease following stem cell transplantation-Reference-Cited by-同舟云学术

Pre‐emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein–Barr virus‐associated lymphoproliferative disease following stem cell transplantation

Published:2011-09-13 Issue:3 Volume:155 Page:377-385
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Worth Austen¹²,Conyers Rachel³,Cohen Jonathon⁴,Jagani Mamta⁵,Chiesa Robert¹,Rao Kanchana¹,Goulden Nicholas¹,Veys Paul¹,Amrolia Persis J.¹²

Affiliation:

1. Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Children

2. Molecular Immunology Unit, Institute of Child Health, University College London, London, UK

3. Peter MacCullum Cancer Institute, Melbourne, Vic., Australia

4. Immunobiology Unit, Institute of Child Health, University College London

5. Pharmacy Department, Great Ormond Street Hospital, London, UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2011.08855.x

Reference28 articles.

1. Selective depletion of bone marrow T lymphocytes with anti‐CD5 monoclonal antibodies: effective prophylaxis for graft‐versus‐host disease in patients with hematologic malignancies;Antin J.H.;Blood,1991

2. Detection of Epstein–Barr virus DNA in plasma from patients with lymphoproliferative disease after allogeneic bone marrow or peripheral blood stem cell transplantation;Beck R.;Journal of Clinical Microbiology,1999

3. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

4. Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation

5. Reconstitution of the Epstein-Barr virus–specific cytotoxic T-lymphocyte response following T-cell–depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation;Transplantation;2024-02-05

2. Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2023-12-29

3. Virus infections after allogeneic stem cell transplantation in children. Review;EJC Paediatric Oncology;2023-12

4. Herpes Virus Infection in Lung Transplantation: Diagnosis, Treatment and Prevention Strategies;Viruses;2023-11-27

5. Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients;Transplant International;2023-11-17